Aeglea BioTherapeutics

0 followers

‌

Aeglea BioTherapeutics is a clinical-stage biotechnology company redefining the potential of human enzyme therapeutics to benefit people with rare and devastating metabolic diseases with limited treatment options.

Industries

Biotechnology

Headquarters

Austin, United States

Employees

51-200

Links

Org chart

Russell J. Cox

Chief Executive Officer, Epirium Bio

Russell J. Cox

Collapse

Cortney Caudill

Chief Product Officer

Eric Bradford

Chief Development Officer

Gillian Bubb

Senior Director Clinical Science, Clinical Development. Rare Genetic Disease

Teams

Product Management Team

6 members

Clinical Development Team

3 members

Leadership Team

3 members

Similar companies

Nkarta

1 follower

Thermo Fisher Scientific

166 followers

Genentech

150 followers

Formation Bio

2 followers

Illumina

67 followers

Agilent Technologies

63 followers

Kura Oncology

18 followers

Charles River Laboratories

11 followers

Cytiva

10 followers

Avantor

10 followers

Ultragenyx Pharmaceutical

10 followers

Explore companies